miércoles, 6 de marzo de 2019

Potential CF Therapy MRT5005 Moving Forward Through Phase 1/2 Trial

Potential CF Therapy MRT5005 Moving Forward Through Phase 1/2 Trial

Cystic Fibrosis News Today

Translate Bio Advancing MRT5005 Through Ongoing Phase 1/2 Trial in CF Patients

No hay comentarios:

Publicar un comentario